Simplify Logo

Full-Time

Senior FP&a Analyst

Posted on 6/27/2024

Visby Medical

Visby Medical

201-500 employees

Provides rapid, portable PCR testing solutions

Biotechnology
Healthcare

Compensation Overview

$100k - $135kAnnually

Senior

San Jose, CA, USA

Salary range for candidates based in San Jose, CA: $100,000 - $135,000. Compensation for the role is based on geographical location.

Category
Financial Planning and Analysis (FP&A)
Finance & Banking
Required Skills
SAP Products
Tableau
Oracle
Requirements
  • BA/BS with 5+ years of experience in financial planning and analysis or another discipline with similar analytical rigor
  • Familiarity with US GAAP
  • Experience with ERP systems like NetSuite, SAP, or Oracle Cloud
  • Bonus points for having a dashboarding skillset, especially in Tableau
Responsibilities
  • Contribute to quarterly forecast and budget planning cycles
  • Analyze monthly and quarterly variances
  • Provide decision support to manage KPIs, headcount planning, and project budgets
  • Standardize and automate FP&A reports and dashboards
  • Lead ad hoc strategic and operational projects

Visby Medical provides rapid PCR tests for detecting infectious diseases, delivering results in under 30 minutes. This is much faster than traditional PCR tests, which can take days. Their portable testing kits are designed for use in clinical and mobile lab settings, making them accessible and easy to deploy. Unlike competitors, Visby's tests are instrument-free and compact, fitting in the palm of your hand. The goal is to provide accurate and timely results to improve patient care by reducing wait times and follow-up issues. Visby Medical generates revenue by selling these testing kits to healthcare providers, addressing the high demand for quick and reliable testing.

Company Stage

Series E

Total Funding

$530.5M

Headquarters

San Jose, California

Founded

2012

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

-9%
Simplify Jobs

Simplify's Take

What believers are saying

  • Securing $135 million in Series E funding positions Visby Medical for significant scaling and expansion of their product offerings.
  • FDA Emergency Use Authorization for their respiratory panel test validates the reliability and importance of their technology.
  • Partnerships with organizations like CARB-X and Chiricahua Community Health Centers highlight Visby's role in addressing urgent public health needs.

What critics are saying

  • The competitive landscape in medical diagnostics is intense, with numerous companies vying for market share.
  • Scaling production capacity from tens to hundreds of thousands of units poses significant operational challenges.

What makes Visby Medical unique

  • Visby Medical's portable, instrument-free PCR tests deliver results in under 30 minutes, a significant improvement over traditional PCR tests that take several days.
  • Their compact, hand-held PCR device is a groundbreaking innovation, making rapid testing highly accessible and deployable in various settings.
  • The company's focus on reducing patient callbacks and loss to follow-up addresses critical inefficiencies in the current healthcare system.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE